Table 1.
Classification | Mechanism of action | Type of drug | Examples of drugs | Cancer type | Ref. |
---|---|---|---|---|---|
Alkylating agents | Add alkyl groups to guanine on DNA; create cross links within the DNA | Platinum-based agents | Cisplatin
Carboplatin Oxaliplatin |
Breast, Leukemia, Lymphoma, Multiple Myeloma, Sarcoma, Brain Cancer, Ovary, Lung | [8-10] |
Nitrogen mustards | Chlorambucil
Cyclophosphamide |
||||
Alkylsulfonates | Busulfan | ||||
Antimetabolites | Interfere with vital metabolic pathways by acting as a false substrate during cell cycle synthesis phase | Pyrimidine antagonists | 5-Fluorouracil
Gemcitabine |
Leukemia, Breast, Ovary, Intestinal Tract, Pancreatic, Colorectal | [11-14] |
Purine antagonists | Fludarabine | ||||
Purine analogs | 6-Mercaptopurine | ||||
antifolates | Methotrexate | ||||
Ribonucleotide reductase inhibitors | Hydroxyurea | ||||
Mitotic spindle inhibitors | Inhibit microtubule polymerization causing disruption of mitotic spindle formation | Taxanes | Paclitaxel
Docetaxel |
ALL, Burkitt lymphoma, Hodgkin lymphoma, Neuroblastoma, Rhabdomyosarcoma, Wilms tumor, NSCLC, Ovarian, Head and neck | [14,15] |
Vinca alkaloids | Vincristine
Vinblastine |
||||
Topoisomerase inhibitors | Prevents resealing of DNA breaks | Topoisomerase inhibitors I and II | Topotecan
Etoposide |
Leukemia,
Lung, ovarian, gastrointestinal, and other cancers |
[14,16] |
anti-tumor antibiotics | Different mechanisms (free radical formation, lipid peroxidation, direct membrane effects, and enzyme interactions) | Anthracyclines | Doxorubicin | ALL, AML, Hodgkin’s and non-Hodgkin’s lymphoma, Bladder, Breast, Metastatic cancers, Esophageal | [14,17,18] |
Daunorubicin | |||||
Tyrosine kinase inhibitors | Blocks the action of tyrosine kinases | Small molecules inhibitors | Erlotinib
Lapatinib Ripretinib |
Breast, CML, NSCLC, Lung, Renal, Hepatocellular, Prostate, Renal, Colorectal, ALL, GIST | [19-22] |
Abbreviations: ALL: acute lymphocytic leukemia, AML: acute myeloid leukemia, CML: chronic myelogenous leukemia, NSCLC: non-small-cell lung carcinoma, GIST: gastrointestinal stromal tumors